Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation
N. Shulzhenko et al., Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation, TRANSPLANT, 72(10), 2001, pp. 1705-1708
Background. The purpose of the present study was to investigate transcripts
of perforin, granzyme B, and Fas ligand (FasL) in heart transplants underg
oing rejection.
Methods. Quantitative reverse transcriptase-polymerase chain reaction was a
pplied for mRNA detection in 29 endomyocardial biopsy specimens from 11 car
diac allograft recipients.
Results. The mRNA levels of granzyme B, perforin, and FasL were higher (P<0
.05) in biopsy specimens with rejection than in biopsy specimens without re
jection (granzyme B, 0.53 vs. 0.09; perforin, 0.34 vs. 0; FasL, 0.57 vs. 0.
36). In prerejection biopsy specimens, granzyme B and FasL levels were sign
ificantly higher than in biopsy specimens without rejection. Any two of the
three transcripts were increased in 100% of prerejection, in 92% of reject
ion, and in 36% of no rejection biopsy specimens (P<0.04).
Conclusions. The assessment of intragraft levels of cytotoxic T lymphocyte
effector molecule mRNA represents a valuable tool in the monitoring of card
iac allograft rejection, especially considering the predictive value for wa
rning of impending acute rejection.